Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be c...
Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candida...
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...
Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to ...
Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular d...
Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire A...
Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, prem...
Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to...
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...
Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...
Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...
Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...
Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...
Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rD...
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...
Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, fr...
Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for t...
